Validation of a longitudinally measured surrogate marker for a time-to-event endpoint

DOI10.1080/0266476022000023776MaRDI QIDQ3591808zbMATH OpenOpenAlexWikidataFDO

Authors Helena Geys, Geert Molenberghs, Tomasz Burzykowski, Marc Buyse, Tony Vangeneugden, Luc Bijnens, Didier Renard

Publication date 11 September 2007

Published in Journal of Applied Statistics (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1080/0266476022000023776

Mathematics Subject Classification ID

Statistics (62-XX)

Recommendations

• Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points
• Validation of surrogate markers in multiple randomized clinical trials with repeated measurements
• Evaluation of longitudinal surrogate markers
• Surrogate Marker Evaluation from an Information Theory Perspective
• The evaluation of surrogate endpoints.

Cited in

(8)

• Prentice's Approach and the Meta-Analytic Paradigm: A Reflection on the Role of Statistics in the Evaluation of Surrogate Endpoints
• Center-within-trial versus trial-level evaluation of surrogate endpoints
• A review on joint models in biometrical research
• Intermediate clinical events, surrogate markers and survival
• Solutions for Surrogacy Validation with Longitudinal Outcomes for a Gene Therapy
• Evaluation of longitudinal surrogate markers
• An information-theoretic approach to surrogate-marker evaluation with failure time endpoints
• Statistical evaluation of surrogate endpoints with examples from cancer clinical trials

This page was built for publication: Validation of a longitudinally measured surrogate marker for a time-to-event endpoint

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3591808)